2-[(3R)-3-amino-4,4-difluoropiperidin-1-yl]-N-(3-sulfamoylphenyl)quinoline-3-carboxamide
C21H21F2N5O3S — CID 169264592
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(3R)-3-amino-4,4-difluoropiperidin-1-yl]-N-(3-sulfamoylphenyl)quinoline-3-carboxamide
2-[(3R)-3-amino-4,4-difluoropiperidin-1-yl]-N-(3-sulfamoylphenyl)quinoline-3-carboxamide (PubChem CID 169264592) has the molecular formula C21H21F2N5O3S and a molecular weight of 461.49 g/mol. Its IUPAC name is 2-[(3R)-3-amino-4,4-difluoropiperidin-1-yl]-N-(3-sulfamoylphenyl)quinoline-3-carboxamide.
Molecular Properties
| Compound Name | 2-[(3R)-3-amino-4,4-difluoropiperidin-1-yl]-N-(3-sulfamoylphenyl)quinoline-3-carboxamide |
|---|---|
| PubChem CID | 169264592 |
| Molecular Formula | C21H21F2N5O3S |
| Molecular Weight | 461.49 g/mol |
| Exact Mass | 461.13 |
| IUPAC Name | 2-[(3R)-3-amino-4,4-difluoropiperidin-1-yl]-N-(3-sulfamoylphenyl)quinoline-3-carboxamide |
| SMILES | N[C@@H]1CN(c2nc3ccccc3cc2C(=O)Nc2cccc(S(N)(=O)=O)c2)CCC1(F)F |
| InChI | InChI=1S/C21H21F2N5O3S/c22-21(23)8-9-28(12-18(21)24)19-16(10-13-4-1-2-7-17(13)27-19)20(29)26-14-5-3-6-15(11-14)32(25,30)31/h1-7,10-11,18H,8-9,12,24H2,(H,26,29)(H2,25,30,31)/t18-/m1/s1 |
| InChIKey | BSWSVNZIZWJLMD-GOSISDBHSA-N |
| XLogP | 2.31 |
| TPSA | 131.41 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 461.49 |
| LogP ≤ 5 | 2.31 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 169264592 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.